Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
I124882-1mg | 1mg | In stock | $28.90 | |
I124882-5mg | 5mg | In stock | $117.90 | |
I124882-10mg | 10mg | In stock | $141.90 | |
I124882-50mg | 50mg | In stock | $426.90 | |
I124882-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $747.90 |
An isoxazole class pan-BET family inhibitor.
Synonyms | 1300031-49-5|I-BET151|GSK1210151A|I-BET151 (GSK1210151A)|7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one|GSK1210151A (I-BET151)|CHEMBL2017291|(R)-7-(3,5-dimethylisoxazol-4-yl)-8-methoxy-1-(1-(pyrid |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of bromodomain containing 2;Inhibitor of bromodomain containing 3;Inhibitor of bromodomain containing 4 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 7-(3,5-dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-pyridin-2-ylethyl]-3H-imidazo[4,5-c]quinolin-2-one |
---|---|
INCHI | InChI=1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1 |
InChi Key | VUVUVNZRUGEAHB-CYBMUJFWSA-N |
Canonical SMILES | CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)C(C)C5=CC=CC=N5)OC |
Isomeric SMILES | CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)[C@H](C)C5=CC=CC=N5)OC |
WGK Germany | 3 |
PubChem CID | 52912189 |
Molecular Weight | 415.44 |
ChEMBL Ligand | CHEMBL2017291 |
---|---|
PubChem CID | 52912189 |
CAS Registry No. | 1300031-49-5 |
RCSB PDB Ligand | 1GH |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J2220287 | Certificate of Analysis | Aug 15, 2024 | I124882 |
J2220293 | Certificate of Analysis | Aug 15, 2024 | I124882 |
J2220299 | Certificate of Analysis | Aug 15, 2024 | I124882 |
J2220300 | Certificate of Analysis | Aug 15, 2024 | I124882 |
J2220303 | Certificate of Analysis | Aug 15, 2024 | I124882 |
Solubility | DMSO 100 mM Ethanol 100 mM |
---|
Pictogram(s) | GHS06 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed |
Precautionary Statements | P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P316:IF SWALLOWED: Get emergency medical help immediately. |
WGK Germany | 3 |
1. Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, Robson SC, Chung CW, Hopf C, Savitski MM et al.. (2011) Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.. Nature, 478 (7370): (529-33). [PMID:21964340] |
2. Bamborough P, Diallo H, Goodacre JD, Gordon L, Lewis A, Seal JT, Wilson DM, Woodrow MD, Chung CW. (2012) Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.. J Med Chem, 55 (2): (587-96). [PMID:22136469] |